Baxter Agrees to Buy Sweden’s Gambro for $2.8 Billion

Baxter International Inc., the world’s second-largest maker of dialysis products, agreed to buy Swedish competitor Gambro AB for 18.3 billion kronor ($2.8 billion) to expand its kidney-equipment business.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.